Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HCAR3 | P49019 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9679025 | 0.89 | HTT (0.40) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9026367 | 0.83 | ALDH1A1 (0.44) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9676736 | 0.79 | ALDH1A1 (0.44) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL18691753 | 0.78 | HCAR3 (0.41) | MAPTGAAHCAR3ALDH1A1HPGD | |
| SCHEMBL14996208 | 0.78 | CA1 (0.49) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9676766 | 0.77 | HTT (0.44) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9678240 | 0.76 | ESR1 (0.43) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9678182 | 0.76 | ESR1 (0.43) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL9679692 | 0.76 | ESR1 (0.43) | HTTTP53MAPTCA1CA2 | |
| SCHEMBL8646438 | 0.76 | ESR1 (0.43) | HTTTP53MAPTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107011924-B | Photoalignment materials with side substitution | 罗利克有限公司 | 2021-06-01 | — | — | CN | disclosed |
| EP-2534191-B1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| EP-2534191-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | Rolic AG (CH) | 2012-12-19 | — | — | EP | disclosed |
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2012-12-13 | — | — | US | disclosed |
| WO-2011098461-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | ROLIC AG (CH) | 2011-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316317-A1 | PHOTOALIGNING MATERIAL WITH LATERAL SUBSTITUTION | LATS1, LATS2, LCP1 | HTT 644/4885TP53 1255/4885MAPT 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.